APSF is pleased to recognize the following companies for their exceptional level of support of APSF
2024 Corporate Advisory Council
Platinum Level ($50,000)
Eagle Pharmaceuticals (eagleus.com)
Edwards Lifesciences (edwards.com) is a global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring.
Driven by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives.
Fresenius Kabi (fresenius-kabi.us) is a global health care company that specializes in lifesaving medicines and technologies that are used to help care for critically and chronically ill patients, offering injectable medicine portfolios for anesthesia providers and a growing number of ready-to-administer products.
GE Healthcare (gehealthcare.com) is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, that enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform.
Vertex Pharmaceuticals (vrtx.com). At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases.
Gold Level ($30,000)
 BD |
 Blink Device Company |
 ICU Medical |
 Medtronic |
 Nihon Kohden America |
 Preferred Physicians Medical Risk Retention Group |
Silver Level ($15,000)
Dräger
IntelliGuard
Bronze Level ($10,000)
Merck
Senzime
Special recognition and thank you to Medtronic for their support and funding of the APSF/Medtronic Patient Safety Research Grant ($150,000).
For more information about how your organization can support the APSF mission and participate in the 2023 Corporate Advisory Council, go to: apsf.org or contact Sara Moser at: [email protected].